119 results
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
idosos
I/C
prevenção de quedas, não-prevenção
O
prevenção de quedas
P
NAFLD, elderly, pre-LT type II diabetes mellitus
I/C
de novo PTMS, other liver diseases
O
cardiovascular disease events
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
patients with de novo coronary artery lesions
I/C
drug-coated balloon (DCB) treatment, non-DCB devices (such as plain old balloon angioplasty (POBA), bare-metal stents (BMS), or drug-eluting stents (DES))
O
target lesion revascularization (TLR)
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
P
patients with De Quervain's Disease (DQD)
I/C
therapeutic taping, other physical therapy interventions, ultrasound and exercise, ultrasound and Mulligan Pain Releasing Phenomenon, phonophoresis
O
pain, power grip strength, precision grip strength, function
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia
P
cholangiocarcinoma (CCA) patients
I/C
meta-analysis of pooled miRNA microarray data, differentially expressed (DE) miRNAs in CCA vs. normal tissues
O
identification of dysregulated miRNAs and their target genes involved in cancer pathways
P
NAFLD, liver transplantation, post-LT HS
I/C
liver transplantation, de novo hepatic steatosis, recurrent hepatic steatosis
O
prevalence of post-LT steatohepatitis, risk factors for HS, effect on liver cirrhosis or mortality